Cite
APA Citation
Berenson, J., Manges, R., Badarinath, S., Cartmell, A., McIntyre, K., Lyons, R., Harb, W., Mohamed, H., Nourbakhsh, A., & Rifkin, R. (n.d.). a phase 2 safety study of accelerated elotuzumab infusion, over less than 1 h, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma. American journal of hematology, 92(5), 460–466. http://access.bl.uk/ark:/81055/vdc_100045397927.0x000041